Use your antibodies-online credentials, if available.
RUNX3 encodes a member of the runt domain-containing family of transcription factors. 再加上，我们可以发RUNX3 蛋白 (11) 和 RUNX3 试剂盒 (4)和数多这个蛋白质的别的产品。
Showing 10 out of 227 products:
Human Monoclonal RUNX3 Primary Antibody for ICS, IHC (p) - ABIN2689899
Chuang, Ito, Ito: RUNX family: Regulation and diversification of roles through interacting proteins. in International journal of cancer. Journal international du cancer 2013
Show all 6 Pubmed References
Human Polyclonal RUNX3 Primary Antibody for EMSA - ABIN3434042
Peng, Wei, Wang, Tang, Zhang, Le, Jia, Li, Xie: RUNX3 inhibits the expression of vascular endothelial growth factor and reduces the angiogenesis, growth, and metastasis of human gastric cancer. in Clinical cancer research : an official journal of the American Association for Cancer Research 2006
Show all 6 Pubmed References
Human Polyclonal RUNX3 Primary Antibody for ELISA, WB - ABIN560191
Nakamura, Senzaki, Yoshikawa, Nishimura, Inoue, Ito, Ozaki, Shiga: Dynamic regulation of the expression of neurotrophin receptors by Runx3. in Development (Cambridge, England) 2008
Show all 5 Pubmed References
Human Monoclonal RUNX3 Primary Antibody for CyTOF, FACS - ABIN4899364
Chopin, Seillet, Chevrier, Wu, Wang, Morse, Belz, Nutt: Langerhans cells are generated by two distinct PU.1-dependent transcriptional networks. in The Journal of experimental medicine 2013
Show all 2 Pubmed References
Human Polyclonal RUNX3 Primary Antibody for IF, IHC (p) - ABIN658684
Zhu, Xu, Hu, Feng, Jiang, Hou, Cao, Han, Ling, Ge: Pim-1 acts as an oncogene in human salivary gland adenoid cystic carcinoma. in Journal of experimental & clinical cancer research : CR 2015
Human Monoclonal RUNX3 Primary Antibody for ICC, FACS - ABIN1724742
Mei, Bai, Liu, Li, Wu, Yu, Zheng: RUNX3 expression is lost in glioma and its restoration causes drastic suppression of tumor invasion and migration. in Journal of cancer research and clinical oncology 2011
Human Polyclonal RUNX3 Primary Antibody for IF, IHC (p) - ABIN514065
Shi, Wang, Liu, Chen: Inactivation of RUNX3 predicts poor prognosis in esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy. in Medical oncology (Northwood, London, England) 2014
In neuronal fate determination, Runx co-factor Cbfbeta (显示 CBFB 抗体) is essential for its function, but the high level of Runx3 expression can overcome the loss of Cbfbeta (显示 CBFB 抗体), demonstrating that Cbfbeta (显示 CBFB 抗体) in this context serves solely as a signal amplifier of Runx3 activity.
successive induction of the transcription factors Runx3, Egr1 and Sox9b constitutes a regulatory cascade that controls expression of Follistatin A in pharyngeal endoderm, the latter modulating BMP signaling in developing cranial cartilage in zebrafish
Runx3 expression leads to an increase in primitive blood cell numbers, together with an increase in runx1 (显示 RUNX1 抗体)-expressing cells in the ventral wall of the dorsal aorta.
Zebrafish embryos lacking Rad21 (显示 RAD21 抗体), or cohesin subunit Smc3 (显示 SMC3 抗体), fail to express runx3 and lose hematopoietic runx1 (显示 RUNX1 抗体) expression in early embryonic development.
These results demonstrate that the CRISPR/Cas9 system is effective in inducing mutations on a specific locus of genome and the RUNX3 knockout pigs can be useful resources for human cancer research and to develop novel cancer therapies.
Runx3-deficient CD8 (显示 CD8A 抗体)(+) cytotoxic effector T cells aberrantly upregulated genes characteristic of follicular helper T (TFH) cell lineage, including Bcl6 (显示 BCL6 抗体), Tcf7 (显示 TCF7 抗体) and Cxcr5 (显示 CXCR5 抗体). Mechanistically, the Runx3-CBFbeta (显示 CBFB 抗体) transcription factor complex deployed H3K27me3 to Bcl6 (显示 BCL6 抗体) and Tcf7 (显示 TCF7 抗体) genes to suppress the TFH program.
Deletion of Runx3 in the peripheral nervous system or specifically in peripheral sensory neurons, or of enhancer elements driving Runx3 expression in proprioceptive neurons, induced prepubertal scoliosis.
We found that Runx3 exerted a positive effect on early myeloid development
Runx3 plays a crucial role in the hypothalamo-pituitary-gonadal axis
intricate combinatorial interplay among the three regulatory elements governs Runx3 expression in distinct subtypes of TrkC (显示 NTRK3 抗体) neurons while concomitantly extinguishing its expression in non-TrkC (显示 NTRK3 抗体) neurons
this study identifies a compensatory signaling mechanism that prevents lineage-fate errors by dynamically modulating Runx3d induction rates during MHC I positive selection
our data suggest that Runx3 may play a crucial role in the development of DRGs by regulating the expression of Ntrk3 (显示 NTRK3 抗体) variants
Runx3 is crucial for the phenotypic and functional changes observed in ThPok (显示 ZBTB7B 抗体)-deficient invariant natural killer T cells.
the transcription factor Runx3 was essential for the normal development of subsets of innate lymphoid cells (ILCs) in the mucosa
Runx1 and Runx3 are the downstream effectors of Nanog, especially in the early and intermediate osteogenic differentiation of the mouse mesenchymal cell line C3H10T1/2.
RUNX3 mRNA and protein expression were upregulated in nasal-type extranodal NK/T-cell lymphoma (NKTL) patient samples and NKTL cell lines compared to normal NK cells. RUNX3 silenced NKTL cells showed increased apoptosis and reduced cell proliferation. MYC (显示 MYC 抗体) and RUNX3 binding occurs. Potential binding sites for MYC (显示 MYC 抗体) were identified in the RUNX3 enhancer region.
The methylation status of Runx3 gene are abnormal in Hepatocellular Carcinoma patients, which may further be used as molecular markers for early diagnosis of Liver cancer.
RUNX 3 hypermethylation is associated with breast cancer.
High RUNX3 expression is associated with gastric cancer.
we present evidence that RUNX3 can act as a tumor suppressor in a human T-cell malignancy and suggest that this effect is predominantly mediated through transcripts from its distal promoter, in particular RUNX3/p46 (显示 POLDIP3 抗体).
Our results from clinical samples also suggest that Threonine 209 phosphorylation by Pak1 (显示 PAK1 抗体) could be a potential therapeutic target and of great clinical relevance with implications for Runx3 inactivation in cancer cells where Runx3 is known to be oncogenic. The findings presented in this study provide evidence of Runx3-Threonine 209 phosphorylation as a molecular switch in dictating the tissue-specific dualistic functions
RUNX3 acts as a tumour suppressor
MicroRNA-145 could regulate the balance of Th1 (显示 TH1L 抗体)/Th2 through targeting the RUNX3 in asthma patients.
The miR (显示 MLXIP 抗体)-29b/KDM2A (显示 KDM2A 抗体) axis was involved in the RUNX3-mediated inhibition of gastric cancer cell proliferation and metastasis.
RUNX3 methylation level is associated with gastric cancer (GC), especially the methylation at site -1415 contributes to the poor prognosis in GC.
This gene encodes a member of the runt domain-containing family of transcription factors. A heterodimer of this protein and a beta subunit forms a complex that binds to the core DNA sequence 5'-PYGPYGGT-3' found in a number of enhancers and promoters, and can either activate or suppress transcription. It also interacts with other transcription factors. It functions as a tumor suppressor, and the gene is frequently deleted or transcriptionally silenced in cancer. Multiple transcript variants encoding different isoforms have been found for this gene.
runt-related transcription factor b
, runt-related transcription factor 3
, core-binding factor 3
, PEA2-alpha C
, PEBP2-alpha C
, SL3-3 enhancer factor 1 alpha C subunit
, SL3/AKV core-binding factor alpha C subunit
, acute myeloid leukemia 2 protein
, core binding factor alpha 3
, core-binding factor subunit alpha-3
, oncogene AML-2
, polyomavirus enhancer-binding protein 2 alpha C subunit
, runt domain, alpha subunit 3
, transcription factor AML2/CBFA3
, PEA2 alpha C
, PEBP2 alpha C
, acute myeloid leukemia gene 2
, core-binding factor, runt domain, alpha subunit 3
, transcription factor AML2
, Runt related transcription factor 3
, Runx3 MASN-variant